Pre-Conference Workshop Day
9:00 am Check In & Coffee
9:30am-12:30pm Workshop A
Corporate Development Strategies to Raise Money for Nasal Drug Companies
Synopsis
The value of effectively conveying value and reduce perceived risk for potential investors is important. Why is raising capital for nasal drug companies so tough? How do you convey the unique value of a niche market like nasal drug delivery to investors who may not see the ROI? And with high R&D costs and complex regulatory hurdles, can investors be convinced of a long-term payoff?
This workshop will cover:
- Frameworks around securing money for startup and the different routes that are available
- Deciding when, how much, and from who?
- Case-study led insights to secure funding and futureproof successful entry to market
12:30 pm Lunch
1:30pm-4:30pm Workshop B
Advancing the Potential of Non-Solution Nasal Delivery Through Innovative Formulation & Delivery Techniques
Synopsis
There has been growing interest in the use of non-solution nasal delivery such as powder formulations. However, many challenges remain, such as how different types of powders impact different devices, where in the nasal cavity it deposits, how much moisture is required to dissolve the powder, suitability for emergency use, and distinguishing between the different patterns of sinonasal obstruction.
This workshop will gather experts to discuss:
- Navigating various non-solution formulations, such as powders, gels, and suspensions, highlighting their advantages in stability, targeted delivery, and prolonged residence time in the nasal cavity
- Discussion on cutting-edge delivery techniques, including dry powder inhalers and aerosolization methods, that enhance the efficacy of non-solution nasal formulations and optimize drug deposition in target areas
- Insights into strategies for improving patient acceptance and compliance through user-friendly delivery devices and formulation characteristics that minimize irritation and enhance the overall nasal delivery experience